Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
2 NC counties are under alert, including Johnston County.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
(OP:
NUMIF
)
0.0237
+0.0015 (+6.76%)
Streaming Delayed Price
Updated: 2:46 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
59,235
Open
0.0237
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.0222
Today's Range
0.0222 - 0.0252
52wk Range
0.0180 - 0.1800
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Psychedelics Co. Numinus Narrows Loss In Q3, Reports QoQ Decrease In Revenue, Gross Profit
July 12, 2024
Psychedelics-focused mental health care company Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF), announced on Thursday its third quarter financial results for the three months ended May 31, 2024."In...
Via
Benzinga
Psychedelics-Focused Numinus Plans To Leverage This AI Technology Via New Strategic Acquisition
June 22, 2024
Psychedelics-focused mental healthcare company Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23) plans to take over MedBright AI Investments Inc. (CSE: MBA).The proposed transaction comes as...
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Performance
YTD
-73.22%
-73.22%
1 Month
-23.05%
-23.05%
3 Month
-48.48%
-48.48%
6 Month
-70.34%
-70.34%
1 Year
-81.98%
-81.98%
More News
Read More
Numinus Wellness Q2 2024 Revenue Declines Amid Clinic Reshuffling And Expected Industry Trends
April 15, 2024
Via
Benzinga
Two Top Biotechs Forge MDMA Supply Deals For Clinical Research
March 26, 2024
Via
Benzinga
Utah Hospitals Will Soon Provide Psilocybin And MDMA Therapy For Mental Health Conditions
March 25, 2024
Via
Benzinga
Psychedelics Headlines: Substitution Survey, Frank Herbert's Magic Mushrooms, Celestial Plans And News Review
March 16, 2024
Via
Benzinga
Psyched: Psychedelics & Sex, MDMA And Federal Approval, Canadians For End-Of-Life Care And More
February 15, 2024
Via
Benzinga
Why Is MindMed (MNMD) Stock Up 8% Today?
February 12, 2024
Via
InvestorPlace
Exposures
Product Safety
Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More
January 27, 2024
Via
Benzinga
Numinus Wellness Continues Tight Expense Management With Strategic Reviews Underway
January 18, 2024
Via
Benzinga
30 Psychedelics Executives, Scientists & Influencers To Watch In 2024 And Beyond
January 10, 2024
Via
Benzinga
Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More
December 05, 2023
Via
Benzinga
Numinus Reports Q4 & Full Year Fiscal 2023 Results, Including Greatly Reduced Cash Burn Rate
November 30, 2023
Via
Benzinga
Psychedelics Researchers & Industry Leaders Weigh In On Groundbreaking PTSD Treatment News
September 15, 2023
Via
Benzinga
NY Consulting Firm Predicts Psychedelic Drugs Market Will Generate Over $12B In Next 12 Years
September 12, 2023
Via
Benzinga
Global Psychedelic Therapeutics Market Size Expected To Reach $13.29 Billion By The Year 2031
July 26, 2023
Via
FinancialNewsMedia
Small Cap Growth Virtual Investor Conference: Presentations Now Available for Online Viewing
July 14, 2023
From
Virtual Investor Conferences
Via
GlobeNewswire
Small Cap Growth Virtual Investor Conference Agenda Announced for July 13th
July 10, 2023
From
Virtual Investor Conferences
Via
GlobeNewswire
MDMA Deals: Optimi Supplies Numinus-MAPS Program & PharmAla Exports To Australian University
June 20, 2023
Via
Benzinga
Numinus Partners With MAPS To Conduct Phase 1 MDMA Assisted Therapy Investigational Study
June 16, 2023
Via
Benzinga
Numinus' Clinical Arm To Lead Enrollment Site For MindMed's Phase 2b LSD Study
June 05, 2023
Via
Benzinga
Psyched: LSD Microdosing For Depression, DMT For Anxiety, MDMA Octopuses And More
May 31, 2023
Via
Benzinga
Numinus' Clinical Site Joins Compass' Phase 3 Program On Psilocybin Therapy For TRD
May 30, 2023
Via
Benzinga
Psyched: LSD For Major Depression, Canada's Psilocybin Macrodose Trial, Treatments For Multiple Sclerosis And More
April 24, 2023
Via
Benzinga
Numinus Wellness CEO Payton Nyquvest On Q2 2023 Financial Results And Numinus Network
April 19, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.